Acute Stroke Patient Articles & Analysis
10 news found
FDA Fast Track Designation for the prevention of stroke in patients after a non-cardioembolic ischemic stroke, which was granted in 2022. ...
ByBayer AG
Oodatroltide addresses the needs of more than 70% of acute ischemic stroke (AIS) patients who are either ineligible to receive proper therapy or are dissatisfied with the treatment outcome. The drug improves stroke treatment rates while expanding treatment coverage, providing neuroprotection, and reducing irreversible damage to ...
Robot-assisted therapy (RAT) is of significant interest in early rehabilitation, when neuroplasticity is high but motor control is frequently insufficient for patients to independently practice functional movements. Many patients with stroke experience persistent upper limb (UL) impairments. This single-blind, randomized, controlled trial[i] ...
ByAxinesis
The European Stroke Organization has chosen “Sonothrombolysis in Patients With Acute Ischemic Stroke With Large Vessel Occlusion: An Individual Patient Data Meta-Analysis” for the September 2021 “Paper of the ...
” Designed as a multi-specialty study, the Imperative Trial will enroll 262 patients at up to 30 sites in the United States and includes investigators from several specialties trained to treat ischemic stroke, including neurosurgery, interventional radiology, and interventional neurology. ...
Stroke has published “Sonothrombolysis in Patients With Acute Ischemic Stroke With Large Vessel Occlusion: An Individual Patient Data Meta-Analysis”. This meta-analysis uses individual patient data from 7 different randomized controlled trials, including the CLOTBUST-ER trial, to show ...
"The current leading interventions for stroke are effective only in the few hours post-stroke and applicable to less than 5-10% of patients. This technology may have the ability to extend the time period in which corrective therapy can be delivered from hours to days and even weeks, and be applicable to a much larger patient ...
The company is the twenty-first start-up instituted by Khosravi via Incept LLC, a medical technology accelerator and development company that has successfully innovated various medical technologies that treat more than a million patients a year globally. “For any ischemic stroke procedure, getting to the brain quickly with the right tools to remove clots ...
The Ramazzini hospital in Carpi (Modena, Italy) has chosen a SIMAD mobile C-arm to be part of the Stroke Unit dedicated to the surveillance and treatment of acute stroke patients. ...
Wilder was President and CEO of PhotoThera, Inc., a company that was developing a unique therapy for acute ischemic stroke patients. Prior to this, Mr. Wilder served as President and CEO of Micro Therapeutics, Inc. ...